SCHEMBL26620751

SCHEMBL26620751

CC(C)CCCC(C)CCc1ccco1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
USP2 O75604 2/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
HPGD P15428 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CHRM2 P08172 1/20 0.35
FNTA P49354 1/20 0.35
PGGT1B P53609 1/20 0.35
BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4956554 0.85 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL6480789 0.85 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL31498246 0.82 ALDH1A1 (0.54) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL19185911 0.80 ALDH1A1 (0.45) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL11469262 0.79 ALDH1A1 (0.44) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL25237379 0.74 ALDH1A1 (0.46) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL21717728 0.74 ALDH1A1 (0.46) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL3506512 0.74 ALDH1A1 (0.54) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL21729771 0.72 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10USP2CYP3A4
SCHEMBL14273824 0.72 LMNA (0.39) LMNAPOLBSMN1; SMN2FNTAPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807614-B1 Method for making substituted furan compound embodiments and derivatives thereof TRIAD NATIONAL SECURITY, LLC (US) 2023-11-07 US disclosed
US-11807614-B1 Method for making substituted furan compound embodiments and derivatives thereof TRIAD NATIONAL SECURITY, LLC (US) 2023-11-07 US disclosed
US-11807614-B1 Method for making substituted furan compound embodiments and derivatives thereof TRIAD NATIONAL SECURITY, LLC (US) 2023-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11807614-B1 Method for making substituted furan compound embodiments and derivatives thereof FDPS, FLAD1, BLVRB LMNA 4373/4885ALDH1A1 1124/4885KDM4E 2369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.